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The concept that anti-glomerular antibodies might cause glomerulonephritis dates 
back to the beginning of this century, when Lindemann demonstrated the nephrito- 
genic  properties  of  heterologous  anti-kidney  antibodies  (1).  Subsequent  work  on 
nephrotoxic serum nephritis has provided precise information concerning the nature 
and potency of these heterologous nephritogenic antibodies, the location and immuno- 
chemical characteristics of the glomerular antigen, and some of the mediators of in- 
ttammation activated by the antibody-antigen interaction  (reviewed in reference 2). 
A  further  step  toward  implicating  this  pathogenetic  mechanism  in  nephritis  was 
achieved when it was shown that animals immunized with homologous or heterologous 
glomerular  basement  membranes  (GBM)  could  develop glomerulonephritis  (3,  4). 
The demonstration of anti-GBM antibody in the serum and kidneys of such animals 
and the passive serum transfer of this form of nephritis in sheep (5) and rabbits (6) to 
normal homologous recipients provided definitive evidence that an animal could, upon 
appropriate immunization, form nephritogenic anti-GBM antibodies apparently capa- 
ble of producing an autoimmune glomerulonephritis. 
A question still unanswered, however, was whether anti-GBM antibodies were ever 
formed, particularly in man, in the absence of intentional immunization. While there 
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have been disputed reports of circulating anti-kidney antibodies in some patients with 
nephritis and certain other diseases,  the nature of the renal antigen(s)  involved has 
not been established nor has any relationship of such antibodies to the pathogenesis 
of nephritis  been  established.  Similarly,  during the past decade,  there have been 
many immunofluorescent demonstrations of gamma globulin, presumably antibody, 
in the glomeruli of human nephritic kidneys. In none of these, however, has the gamma 
globulin in the glomemli been identified as antibody to GBM or to any other specific 
glomerular antigen. 
The present studies were designed to look for anti-GBM antibodies in human 
nephritis both in the circulation and in the kidneys and, if found, to determine 
their nephritogenic properties~  Anti-GBM antibodies  were found in the serum 
and/or  kidneys  of six nephritic  patients.  These  antibodies  would  react  with 
GBM antigens in vitro and in vivo. On passive transfer,  they induced an im- 
mediate glomerulonephritis in recipient monkeys. 
In  view  of  the  reasonably  well-established  role  of  circulating  antibody- 
nonglomerular antigen complexes in the pathogenesis of serum sickness nephritis 
(7, 8, 9), experimental allergic glomerulonephritis induced with tubular antigens 
(EAG-TA) (10), the nephritis of NZB mice (11),  1 systemic lupus erythematosus 
(12,  13),  and possibly acute poststreptococcal nephritis  (14,  15),  there  would 
appear  to be  at  least  two quite  distinct  and  independent  immunopathogenic 
mechanisms which may operate in different forms of experimental  and human 
glomerulonephritis.  The  relative  frequency  of  these  two  mechanisms  in  the 
various forms of human glomerulonephritis remains to be determined. 
Materials and Metkods 
Analysis of Sera from Nephritic Patients 
250 sera from 50 intact and 25 bilaterally  nephrectomized patients  were obtained  from 
several centers. In most cases, these sets were kept at --20°C until used. The diagnoses and 
clinical courses of the patients  were obtained from the physicians in charge. 47 of the intact 
patients were diagnosed as having glomerulonephritis (acute poststreptococcal 3, subacute 4, 
chronic 36, unclassified 4). 23 of the bilaterally nephrectomized patients had glomerulonephritis 
(chronic 15, subacute 4, Goodpasture's syndrome 2, unclassified 2). Of the remaining 5 patients, 
3 had chronic pyelonephritis and 2 had polycystic renal disease. 
Gel D/~u~on.--Preparation and characterization of the antigen used in these studies is the 
subject  of separate  reports 2 (16). In brief,  glomerular  basement  membrane  (GBM)  was 
isolated by the method of Krakower and Greenspon (17) from no less than 30 presumably 
normal human kidneys obtained at autopsy. The membranes were pooled and extracted with 
collagenase which solubilized approximately  30% of the membranes.  Soluble material  thus 
obtained was desalted by dialysis, lyophilized, and used in gel diffusion studies. 
The sera described above were tested for their ability to precipitate soluble GBM antigen 
in 1% agarose using both the micro-Ouchterlony technique and Holm's modification of the 
1 Lambert,  P. H., and F. J. Dixon. Unpublished observations. 
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template method described by Hanson (18). Each analysis was done in triplicate using respec- 
tive antigen concentrations of 1000, 500, and 100/zg/ml. In the case of the micro-Ouchterlony 
analysis, if no precipitation was observed after 48 hr at 22°C, the antigen and antiserum wells 
were refilled  several times. 
Indirect  Immunofluorescence.--The levels of circulating anti-GBM antibody when present 
have, in our experience, been so low that small amounts of nonsp~ific uptake of gamma glob- 
ulin by  the test  kidney  sections make indirect immunofluoreseent interpretation  difficult. 
Presumably normal human kidneys obtained at autopsy, or normal renal tissues obtained at 
surgery and stored frozen for several weeks, may give such nonspedfic reactions. Therefore, 
in these studies, in the absence of satisfactory human kidney tissue, the target tissues were 
obtained from a healthy chimpanzee and from healthy Lewis rats sacrificed  for this purpose 
shortly before the studies were performed. 
Sera from all 75 patients mentioned above, plus 60 normal males and females, were diluted 
l: 1 with phosphate-buffered saline, pH 7.2, and then laid over kidney sections for 30 rain. 
The sections were washed twice in saline at room temperature and then stained with fluores- 
cent rabbit anti-human IGG. 
Detailed Studies on Patient G.L. Who Had Precipitating  Antibodies  Against GBM 
Clinical Course.--G.L., in whom detectable amounts of circulating anti-glomerular antibody 
were found during his anephrie period, received a renal allotransplant from his brother. Serial 
samples of serum were obtained prior to and after bilateral nephrectomy and after transplan- 
tation. The course of the renal transplant was judged by 24 hr protein excretion and serum 
creatinine concentration. For comparison, concurrent studies of proteinuria and renal function 
were carried out in five patients with nonglomerular disease (i.e., polycystic renal disease and 
chronic pyelonephritis)  who underwent  renal transplantation  and  had  clinical courses and 
treatment protocols glrnilar to G.L. 
Immunopo~holog~al Studies.-- 
1. Quantiga~ion of the amount  of in ~ivo kidney-fixlng  antibody  (KFAb) in sera from G.L.: 
Several sera from G.L. which precipitated GBM antigens in vitro were pooled and precipitated 
with  ammonium  sulfate at  50~  saturation.  Some of this  ammonium  sulfate-predpitable 
globulin was eluted from a diethylaminoethyl cellulose (DEAE) column with 0.0175  ~¢ phos- 
phate buffer at pH 8.0.  The single protein peak thus obtained was shown to be IGG by im- 
munoelectrophoresis against  rabbit  anti-human  whole serum.  This  IGG was  labeled with 
181I and control human IGG was labeled with 12sI according to the method of McConahey 
and Dixon (19).  Tracer amounts of these two globulins (one labeled with lalI and the other 
with 126I) were simultaneously injected intravenously into two 500 g squirrel monkeys. These 
animals were sacrificed 24 hr after injection and  the blood, kidneys,  liver, spleen,  muscle, 
testicles, and heart were obtained. The ratio of the two isotopes present, as well as the absolute 
amounts fixed, were determined. The amount of 125I- and  13XI-labeled proteins which were 
bound  to  the particulate  kidney  fraction  were  determined  by counting  the  sedimentable 
portion of a homogenate of the kidney which was first repeatedly washed in phosphate-buffered 
saline (PBS) and centrifuged at 2000 g for 15 min. The absolute amount of KFAb  was cal- 
culated according to a previously published formula (5). 
2. Studies  on the allotransplantexl kidney received by G.L.: Biopsies of the allotransplanted 
kidney were performed just prior to and 75 rain after restoration of its blood supply in G.L. 
and 29 days after transplantation.  The tissue obtained was processed  for light  and  immuno- 
fluorescent  microscopy.  Immunofluorescent  reagents  included  fluoresceinated  rabbit  anti- 
human IGG, flxC, albumin, and fibrin. ControLs for specificity of reagents were similar to those 
previously reported (20). 992  ANTI-GLOMERULAE  ANTIBODY  IN  HUMAN  NEPHRITIS 
Transfer of Nephritis  with Serum  From G.L.--500 mg of ammonium sulfate-precipitable 
globulin prepared as described above from a pool of sera containing precipitating anti-GBM 
antibody was injected into each of two unilaterally nephrectomized 500 g squirrel monkeys. 
On the basis of the previous studies, this represented a  total  of  somewhat  less  than  1  mg 
particulate-bound KFAb  or approximately 350  #g/g  of  recipient kidney.  Urinary protein 
excretion was determined by the sulfosalicylic acid method for 3 days prior to and 7 days after 
injection.  A  unilaterally nephrectomized  control monkey  received  500  mg  of  ammonium 
sulfate-precipitable globulin obtained by pooling sera from patients with glomerulonephritis 
who did not have detectable levels of precipitating anti-GBM antibody. Renal tissue obtained 
by biopsy and at sacrifice 1 and 8 days, respectively, after injection was saved for light and 
fluorescent microscopy. The kidney obtained at the time of pretreatment unilateral nephrec- 
tomy served to control all morphological observations. 
Studies of Eluates of Glomerulonephritic Kidneys 
Elution.--Kidneys obtained at nephrectomy from 13 patients with a variety of renal diseases 
were available for this study. Prior to elution, a frozen piece of each kidney was sectioned and 
stained with fluoresceinated rabbit anti-human IGG,  /31c,  and fibrin. After these studies, 
the cortical portion of each kidney was isolated by dissection, mixed with PBS (pH 7.0-7.2), 
and homogenized in a  Waring Blendor at high speed for 3 rain. This homogenate was spun 
at 2000 g in a refrigerated centrifuge for 30 rain at 4°C. The sediment thus obtained was washed 
in PBS and spun as above, repeatedly,  until the supernatant was clear. At this point, the 
sediment, which consisted of particulate renal cortical material essentially freed  from  un- 
bound serum proteins and soluble tissue proteins, was mixed with 0.02 M citrate buffer, pH 
3.2 (I0 parts buffer: 1 part sediment v/v), and incubated at 37°C with constant stirring for 
2 hr. After incubation, the mixture was spun at 2000 g for 30 rain. The resulting supernatant 
fraction was immediately brought to pH  7.0 with 0.1  N NaOH,  and then dialyzed against 
several changes of PBS. During this dialysis, a precipitate formed. In early experiments, this 
precipitate was shown not to contain antibody and in subsequent experiments was discarded. 
Next,  the eluted material was brought to a  protein concentration of 10 mg/ml by pressure 
dialysis and either used at this concentration for indirect fluorescent studies or directly con- 
jugated to fluorescein isothiocyanate (FITC) according to the method of Clark and Shepard 
(21). 
Each eluate was studied by immunoelectrophoresis using rabbit anti-human whole serum, 
albumin,/31c, and IGG. Some eluates were also studied for the presence of IGA with specific 
rabbit anti-human IGA. 
In Vitro Studies with Eluates.--The concentrations of anti-GBM antibody in the positive 
eluates have been so  great  and  the staining in indirect immunofluorescent procedures  so 
intense that the small amount of nonspecific uptake of gamma globulin by human kidneys, 
which was a problem in the search for anti-GBM antibodies in sera, presented no difficulty 
here. 
Normal human kidneys were obtained from two patients immediately after death from 
traumatic injury. The tissue was frozen in liquid nitrogen and used within 1 wk. Tissue sections 
were fixed in ether alcohol (50:50 v/v) for 10 rain, followed by 95% alcohol for 20 min, and 
then washed in PBS. Sections thus prepared were first overlaid for 45 min with the eluates 
described above and then washed twice with PBS for 8  rain. After this,  the sections were 
incubated for 30 rain with fluorescent rabbit anti-human IGG and then washed in two changes 
of PBS. To rule out the chance that either of the two presumably normal human kidneys 
used had preexisting localization of IGG in the glomeruli, control sections were stained directly 
with fluorescent rabbit anti-human IGG. Some studies were done to test the ability of eluates 
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shown to stain human  kidney were tested for their ability to stain  mouse,  rat,  guinea pig, 
rabbit, sheep, and monkey kidney. 
Demonstro2ion of Pathogenicity of Eluates.--Eluate from patient R.G. with Goodpasture's 
disease was precipitated at 50% ammonium sulfate saturation, and  12 mg of the redissolved 
precipitate was injected into a  500 g unilaterally nephrectomized monkey. 6 mg of similarly 
prepared  material  from patient  V.U.  with  subacute  glomerulonephritis  was  injected  into 
another 500 g unilaterally nephrectomized monkey. In spite of the fact that these eluates had 
been previously shown not to agglutinate the recipient monkey's RBC's, they were absorbed 
with a  one-third volume of the recipient monkey's packed RBC's prior to injection. These 
monkeys were studied for proteinuria for 3 days prior to and for 5 days after injection. Renal 
tissue was obtained by biopsy 24 hr after injection. A complete autopsy was done at sacrifice 
or at death 6 days after injections. Tissues thus obtained were studied by light and fluorescent 
microscopy as described above. The kidneys obtained at the time of unilateral nephrectomy 
were used to control the histologic observations. 
RESULTS 
Analysis of Sera from Nepkritic Patients 
Precipitating antibodies against soluble collagenase extracts of human GBM 
were found in the sera of only 2 (G.L. and R.E.) of the 23 bilateral nephrecto- 
mized nephritics and none of the intact patients. The cfinicai and morphological 
diagnosis  for  the  two  positive  cases  was  chronic  active  glomerulonephritis. 
Sufficient serum  for further studies  was  available  only on  G.L.  Anti-GBM 
antibody could not be demonstrated in the sera of G.L. prior to nephrectomy, 
but it was present 5 days after bilateral nephrectomy and persisted in the serum 
for 55 days during the anephric state and disappeared 24 hr after renal trans- 
plantation. During the subsequent 5 months after transplantation,  detectable 
levels of precipitating antibody against GBM have not reappeared in the sera 
of this patient. 
Indirect Imraunofluorescence.--Of the 47 intact nephritic patients, 2 had sera 
which fixed to chimpanzee but not to rat kidney basement membranes, while of 
the 23 nephrectomized nephritics 7 had sera which fixed to chimpanzee but not 
to rat kidney basement membranes.  These reactions could not, however, be 
considered conclusive evidence of specific anti-GBM  antibodies since 6 of 60 
sera from presumed normal humans also fixed, to some extent, to the chimpanzee 
but not to the rat kidney basement membranes. All six of these normal reactors 
were males. The basis of these reactions and their significance are not clear at 
this time. 
However, of the  70  nephritic patients,  14 had readily demonstrable  anti- 
nuclear antibodies reactive with both chimpanzee and rat nuclei, while only 1 of 
the 60 controls showed anti-nuclear antibodies. All of these  15 reactors were 
females, while for the entire series the sex incidence was approximately equal. 
None of the sera with antinuclear antibodies reacted to GBM. Whether the 
anti-nuclear antibodies are causative or contributory to the nephritic process 
or merely incidental by-products of the  disease  cannot be  said.  It  is  clear, 994  ANTI-GLO~[EI~ULA]~  ANTIBODY  IN  HUMAN  NEPHRITIS 
though,  that  the incidence  of anti-nuclear  antibodies in unselected adult pa- 
tients with severe nephritis is high. 
Detailed Studies on Patient G.L. Who Had Precipitating Antlbodies Against GBM 
Clinical Course.--The  details of this patient's clinical course before and after 
transplantation are given in a separate report.  8 In brief, he was a 29 yr old male 
with chronic  active glomerulonephritis  with rapidly progressive  renal failure. 
After institution  of intermittent  hemodialysis,  a  bilateral  nephrectomy was 
performed  in  anticipation  of  renal  allotransplantation.  The  nephrectomy 
specimens  revealed severe chronic  active glomerulonephritis.  55 days after bi- 
lateral  nephrectomy,  a  renal  allotransplant  was performed using his  healthy 
brother as the donor.  Immunosuppressive therapy was begun 1 day prior  to 
transplantation.  In addition, extra corporeal  irradiation of blood and thoracic 
duct fistula were  carried out prior  to transplantation.  Mter  transplantation, 
proteinuria was noted but renal function was excellent. The posttransplantation 
level of proteinuria in G.L.  averaged 3 g per day for the first 2 wk and then 
remained 1 g per day for the next 5 months. In the five nonglomerulonephritic 
control transplanted patients, proteinuria averaged 3 g per day during the first 
posttransplantation week, 1 g per day during the 2nd wk, after which the pro- 
teinuria declined to less than 0.5 g per day. 
Immunopathological Studies.-- 
1. Quantitation of the amount of in vivo KFAb present in sera  from G.L.: In two 
separate experiments,  0.15 and 0.18% of the IGG obtained from the anephric 
patient was specifically bound to the particulate fraction of kidney 24 hr after 
intravenous injection into a  normal squirrel  monkey. That  these percentages 
represent specific antibody is further suggested by the fact that, in each experi- 
ment,  the ratio of experimental globulin  to control globulin  was higher  in the 
kidney than in any other organ or the blood. The kidney-fixing globulin present 
in the serum of this patient was similar  in amount to that found in nephrec- 
tomized sheep with experimentally induced allergic glomerulonephritis  (5). 
2.  Studies on the allotransplanted kidney received by G.L.: Biopsies of the allo- 
transplanted kidney taken 30 min after removal from the donor, (after perfusion 
with bicarbonate-buffered cold Ringer's solution)  and 75 min after restoration of 
blood flow to the graft in the recipient,  revealed no significant  histotogic  glo- 
merular  alterations.  However,  IGG  and  ~31c-globulins were  already  found 
deposited in a linear fashion along the glomerular capillary walls in the 75 min 
biopsy. 29 days after transplantation,  another renal biopsy was taken which 
revealed,  by routine  light microscopy, significant  glomerular  alterations  con- 
slsting  of focal glomerular  basement membrane  thickening  and epithelial  cell 
3 Glassock, R. J., R. A. Lerner, and J. P. Merrill. Report of a  case of recurrent glomeru- 
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proliferation. Lesions of  the  interstitium  and vessels usually associated with 
allograft rejection were notably absent.  Immunohistologic study of this latter 
biopsy revealed uniform linear  deposits  of IGG and  Blc-globulins  along  the 
glomerular capillary walls and focal, weak, irregular deposits of fibrin. Fig. 1 is 
a section of the biopsy obtained at 29 days showing part of a glomerulus incu- 
bated with rabbit anti-human IGG. Control sections of this biopsy incubated 
with  fluorescent anti-human  albumin  and  anti-human  IGG, which  had been 
absorbed with immunochemically pure IGG, showed no staining. 
Transfer  of Nephritis  with  Serum  From  G.L.--The injection of 500  mg of 
globulin obtained from G.L.  (containing slightly less  than  1 mg KFAb)  into 
each of two unilaterally nephrectomized squirrel monkeys resulted in proteinuria 
within 6 hr after injection. The amount of proteinuria went as high as 200 rag/ 
100 ml and lasted for 1 wk.  Control unilaterally nephrectomized monkeys re- 
ceiving 500 mg of globulin from other nephrectomized patients  who did not 
have detectable levels of precipitating antibody against  GBM had only trace 
proteinuria, 5-10 rag/100 ml, lasting only 1-2 days. Renal tissue obtained from 
the monkeys 24 hr after injection of globulin from G.L. showed between 5 and 7 
polymorphonuclear  leukocytes (PMN)  per glomerular cross section, in contrast 
to an average of < 1 PMN per glomerulus from control animals. When this tis- 
sue was stained with fluorescent rabbit anti-human IGG and ~1c, a linear dep- 
osition of IGG and Flc  could be  found along the  glomerular capillary walls. 
The kidneys obtained at the time of sacrifice (7 days after injection) appeared 
normal when examined by the light microscope; however, IGG and ~1c  could 
still be demonstrated along the glomerular capillary walls.  There were no his- 
tologic alterations or deposition  of IGG or ~1c at any time in the glomeruli of 
monkeys injected with control globulin preparations. 
Sludies of Eluates of Glomerulonephritic Kidneys 
Elution.--A total of 13 kidneys were eluted. Seven of these kidneys were from 
patients with chronic glomerulonephritis, two from patients with Goodpasture's 
disease, one from a patient with subacute glomerulonephritis, two from patients 
with  chronic pyelonephritis, and one from a  presumably normal patient who 
died after trauma. In nine cases,  IGG and ~1c were demonstrated in the glo- 
meruli prior to elution. The deposition of IGG and 31c along the glomerular 
capillary walls could be shown with certainty to be uniformly linear in four of 
these  nine cases.  Two of these four patients  had  Goodpasture's disease,  one 
had  chronic  glomerulonephritis,  and  one  had  subacute  glomerulonephritis. 
Fig.  2  is  a  photomicrograph taken  of  a  glomerulus  from  patient  R.G.  with 
Goodpasture's disease  which  was  stained  with  rabbit  anti-human  IGG.  Our 
findings, that  in  this disease  IGG and /~1c are  localized along the glomerular 
capillaries in a linear fashion, confirm the work of others (22, 23).  Fig. 3 shows 
an  entire glomerulus  (a)  and  a  portion of a  glomerulus  (b)  similarly stained 996  ANTI-GLOMERULAR  ANTIBODY  IN  HUMAN  NEPHRITIS 
from a  section of the kidney of patient V.U. with subacute glomerulonephritis. 
Again, the linear deposition of IGG along the glomerular capillary loops should 
be noted.  Because of the severe glomerular injury and scarring in the remain- 
ing  five  cases  of  chronic  glomerulonephritis  where  IGG  was  seen,  the  exact 
pattern  of distribution  could not be determined.  Of the  four kidneys showing 
no localization of IGG or/~1c in the glomeruli prior to elution,  two were from 
patients  with  pyelonephritis,  one from a  normal patient  who died  after  trau- 
matic injury, and one from a patient with chronic sclerosing glomerulonephritis. 
The eluates from the nine kidneys known to have glomerular localization of 
TEx:r-Fm. 1.  IEP comparing the protein content of the unpurified eluate from the kidney 
of patient  R.G. with Goodpasture's disease to normal human serum. It should be noted that 
eluate contains predominantly globulins of 3' mobility. The reason for the relative "fastness" 
of the IGG in the eluate is not known. The trough  is filled with  rabbit  anti-human  whole 
serum. Normal human sera (NHS). 
IGG by immunofluorescence invariably contained  this  globulin in higher  con- 
centration  than any other serum protein.  In one case of Goodpasture's disease 
(R.G.)  and in  the  case of subacute  glomerulonephritis (V.U.),  where sufficient 
renal  tissue  was  available  for quantitation,  approximately  100/~g  of IGG per 
gram of kidney could be eluted with  acid citrate.  Text-fig.  1 is  an IEP which 
compares  the  nature  of the  proteins  contained  in  the  unpurified  eluate  from 
patient  R.G.  with  Goodpasture's  disease  to those  contained in normal human 
serum. It should be noted that the eluate primarily contains IGG and IGA and 
that the IGG is relatively "fast." The identity of IGA was confirmed by using a 
specific  rabbit  anti-human  IGA  antisera  which  was  kindly  supplied  by  Dr. 
Howard Grey. Text-fig. 2 compares the proteins eluted from the kidney of pa- 1~.  A.  LERNER,  R.  J.  GLASSOCK~ AND  F.  J.  DIXON  997 
tient  V.U.  with  subacute  glomerulonephritis  to normal human serum.  In this 
case,  the  eluate  contained only IGG. It should be noted  that  the mobility of 
the IGG in this eluate was similar to that of untreated IGG from normal human 
serum. 
In Vitro Studies with Eluted Antibody.--The eluates from 4 of the 13 kidneys 
fixed strongly to sections of normal human kidney in vitro. These were from the 
T~xT-FIo. 2.  IEP comparing unpurified eluate from patient V.U. with subacute glomeru- 
lonephritis to normal human serum (NHS). The trough on the top is filled with rabbit anti- 
whole human serum and the bottom trough is filled with rabbit anti-human IGG. It should be 
noted that only IGG can be detected in the eluate and that, in this case, the mobility of eluted 
IGG is similar to the IGG contained in NHS. 
four kidneys  showing  linear  deposition  of IGG by immunofluorescence.  Two 
of these kidneys were from the patients  with  Goodpasture's disease, one from a 
patient  with  chronic glomerulonephritis,  and  the fourth from the patient with 
subacute  glomerulonephritis.  There  was  a  discrete  linear  localization  of  the 
eluted globulin along GBM's,  Bowman's capsule,  and tubular basement mem- 
branes  (TBM).  Furthermore,  each  of  these  eluates  stained  GBM,  Bowman's 
capsule,  and TBM of sections of mouse,  rat, guinea pig, rabbit,  pig, lamb,  and 998  ANTI-GLOMERULAR  ANTIBODY  IN  HUMAN  NEPHRITIS 
monkey kidneys. They did not, however, stain sections of human heart, liver, 
or lung.  Fig.  4  shows  a  glomerulus from a  normal human kidney which  was 
first overlaid with  the  eluate obtained from the kidney shown in Fig.  2,  then 
stained with rabbit anti-human IGG. There is deposition of IGG along GBM 
and Bowman's capsule, as well as the TBM. A staining pattern similar to that 
seen in Fig.  4 was seen when the eluate from the kidney shown  in  Fig.  3  was 
reacted with normal human kidney in vitro. The positive staining of rat base- 
ment membranes was  abolished  by absorption of  these  eluates  with  purified 
rat GBM. 
Demonstration  of  Pathogenicity  of  Eluted  Globulins.--The  monkeys  which 
were injected, one with 6 mg of globulin eluted from the kidney of patient V.U. 
and one with  12 mg of globulin eluted from the kidney of patient R.G., devel- 
oped respective proteinurias  of  75  and  200  mg/100  ml during  the  first 24  hr 
after injection.  Control monkeys which received approximately 40 times more 
human acid-treated globulin than these monkeys developed only mild protein- 
uria which never exceeded 20 mg/100 ml. The kidney biopsies obtained 24 hr 
after  injection  showed  PMN  accumulation  in  the  glomeruli  and  moderate 
swelling and proliferation of fixed glomerular cells. There were no abnormalities 
in the glomeruli of these monkeys obtained at the time of unilateral  nephrec- 
t6my before injection of globulin. 
Fig. 5 is a  glomerulus from the biopsy obtained 24 hr after injection of the 
eluate  from patient  V.U.  showing  proliferation of fixed glomerular cells.  Im- 
munofluorescent studies performed on the biopsies obtained 24 hr after injection 
using  anti-human  IGG and ~1c  showed,  in both  cases,  a  linear  deposition  of 
injected IGG and what was presumed to be host Cm along the glomerular cap- 
illary walls. Previous observations showed a  significant cross-reaction between 
anti-human ~1c  and  monkey  ¢hc. Fig.  6  shows  the  linear  deposition  of  IGG 
along the glomerular capillary walls in  the biopsy of the monkey obtained at 
24 hr after injection of the  eluate obtained from patient  R.G.  lqg.  7 is a  low 
power photograph  of the same section shown in Fig.  6  which  emphasizes the 
exclusive in vivo localization of 1GG to the glomeruli in contrast to the in vitro 
reaction with tissue sections where basement membranes of tubules,  etc., were 
also stained.  This difference is presumed to be the  result  of differences in  lhe 
anatomical  availability  of  the  various  basement  membrane  antigens  to  the 
antibody in vivo and in vitro. There was no staining when the kidney removed 
prior to injection was incubated with the same fluorescent reagents used above. 
On the 4th day after injection of the eluate from patient R.G.,  the monkey 
was virtually anuric,  and by the 6th day, the blood urea nitrogen  (BUN)  was 
100 rag/100 ml when the animal died.  Renal tissue obtained at postmortem (6 
days after injection) from this monkey showed proliferation of fixed gtomerular 
cells as well as some casts in the renal tubules. The monkey injected with the 
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injection,  the BUN was 80 mg/100 ml.  In this case,  the kidney obtained at 
sacrifice (6 days after injection) showed severe proliferative glomerulonephritis 
(Figs.  8 and 9). IGG and fllc were still present along the glomerular capillary 
walls  in  the  tissue  obtained from both monkeys 6  days after  injection.  No 
significant  histologic  alterations were found in any organ other than the kidney 
at postmortem examination. Furthermore, when the lung, liver, and heart were 
studied by fluorescent microscopy, no in vivo localization of IGG or tim could 
be demonstrated in either monkey. 
DISCUSSION 
The present experiments establish  the presence of anti-GBM antibodies  in 
some cases  of human  glomerulonephritis  and  offer  considerable  evidence for 
their participation in the pathogenesis of this disease. The finding of circulating 
precipitating  anti-GBM antibodies in two anephric patients,  but in no intact 
patients, is in keeping with the observations made on sheep with experimentally 
induced anti-GBM antibodies,  in which  levels  of these circulating  antibodies 
rose after nephrectomy. Apparently the kidneys, with their GBM exposed to 
the circulation via endothelial pores,  are extremely efficient in removing anti- 
body from the blood. The elution of anti-GBM antibodies from the kidneys of 
four nephritic patients demonstrates not only the presence of these antibodies 
in nephritics but also their localization  in the organ suffering injury.  The pat- 
tern  of  fixation  of  host  IGG,  presumably  the  anti-GBM  antibody,  in  a 
smooth linear fashion along  the glomerular capillary walls corresponds  precisely 
to the distribution  of heterologous anfi-GBM antibodies localized  in vivo in 
nephrotoxic serum  nephritis  and  of autologous  anfi-GBM  antibodies in  the 
autoimmune version of this experimental disease.  The in vitro reactions of the 
serum  and  renal  eluate  antibodies  with  soluble extracts  of homologous  and 
heterologous GBM in gel, plus their reaction with a linear structure in the glo- 
merular capillary walls in frozen sections of kidney, further  support  their  re- 
activity with antigens  of the  GBM. The lack of species specificity in the re- 
action of these eluted antibodies supports the well-recognized fact that there is 
considerable  antigenic  cross-reactivity  among  mammalian  GBM's.  Finally, 
the fixation of these antibodies in a linear fashion along the glomerular capillary 
walls of the kidneys of monkeys to which they had been transferred and of the 
allotransplated kidney in a patient with such antibodies demonstrates not only 
their  immunologic  reactivity but also  their  in vivo effectiveness  in  reaching 
their target antigen. 
The demonstration of in vivo reaction of these human anti-GBM antibodies 
with antigens of the glomerular capillary wall, plus the associated initiation of 
immediate  severe  glomerulonephritis  in  monkeys  receiving  such  antibodies, 
would appear to establish the pathogenicity of these antibodies. As little as 6 
mg of IGG eluted from a nephritic kidney produced severe glomerulonephritis 1000  ANTI-GLOMEI~ULAR  ANTIBODY  IN  HUMAN  NEPHRITIS 
in  a  unilaterally  nephrectomized  monkey.  Equally  convincing  evidence  of 
pathogenicity of these antibodies is provided by the events observed in a pa- 
tient during renal  transplantation.  Detectable circulating  anti-GBM antibody 
appeared first after bilateral nephrectomy of the patient prior to transplanta- 
tion and persisted in the circulation throughout the anephric period. With the 
implantation of a renal allograft,  the antibody promptly disappeared from the 
circulation and host IGG, presumably the antibody, and ~Io accumulated in a 
linear pattern along the glomerular  capillary walls of the transplanted kidney. 
Simultaneously with this deposition of IGG, the kidney developed glomerulone- 
phritis. 
The  in  vitro  behavior  of  antibodies,  presumably anti-GBM,  eluted from 
kidneys with a linear  deposition of IGG along  their glomerular  capillary walls, 
should be contrasted to antibodies eluted from kidneys where IGG is localized 
in a  discontinuous,  granular  fashion,  presumably as a  result of deposition of 
circulating  antibody nonglomerular  antigen  complexes.  The  latter  has  been 
most clearly studied in EAG-TA in the rat (24), the NZB mouse (11), 1 and in 
human systemic lupus erythematosus (SLE)  (12,  13). In EAG-TA, where the 
origin of the antigen has been shown to be the proximal convoluted tubule, acid 
eluates of IGG from nephritic kidneys stained only tubular cells and not normal 
glomernli.  Similarly,  both in patients with SLE and in NZB mice,  where the 
globulin deposited in the kidney is at least in large part antinuclear antibody, 
eluates would only stain nuclei or the nuclear material  deposited in diseased 
glomeruli  and not normal GBM. 
The  most  important  unanswered  questions  remaining  concerning  the  ne- 
phritides  associated with anti-GBM antibodies concern the source of the im- 
munizing  antigen(s)  and the particular events leading  to immunization.  Both 
endogenous  GBM antigens and exogenous materials cross-reactive  with GBM 
are possible  immunogens.  The  recent findings  of GBM antigen(s)  in normal 
animal and human urines and the nephritogenicity of this antigen when it is in- 
jected into the animals  from which it was obtained suggest that such urinary 
antigens might be the immunogens in human nephritis (25).4.5 If normal urine 
and,  therefore,  presumably normal glomerular filtrate contain  GBM antigens 
potentially nephritogenic  to their host, any abnormal handling  of the filtrate 
which might  expose  lymphoid cells  to  the  antigen  would be potentially ne- 
phritogenic.  In such instances,  the presence of infectious agents or other exoge- 
nous materials might have an adjuvant effect on the response.  The additional 
finding that during  active glomerulonephritis  the amount and variety of  these 
GBM antigens in  the urine increase  (25) provides a  possible  self-accelerating 
4  Lerner, R. A., and F. J. Dixon. The induction of acute glomerulonephritis in rabbits by 
injection with soluble autologous and homologous  glomerular basement membrane (GBM) 
antigens isolated from normal urine. To be published. 
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nephritogenic stimulus. The second means of immunizing  to GBM, contact with 
environmental antigens cross-reactive  with GBM, has as yet little experimental 
or clinical support. Claims of cross-reactions  between some streptococcal strains 
and  GBM have been made (26,  27),  but these cross-reactions  have not been 
readily reproduced nor do they always correlate well with the nephritogenicity 
of the  streptococcal strains  employed. Further,  morphological  and  immuno- 
histochemical  observations  suggest strongly  that  poststreptococcal glomeru- 
lonephritis  is  caused by the deposition of circulating  antibody-antigen  com- 
plexes  and  not by anti-GBM  antibodies. 
While the presence  and pathogenetic role of anti-GBM antibodies in some 
cases of glomerulonephritis  seems established,  their incidence  in adult human 
glomerulonephritis  is still not dear. The present method of testing sera for anti- 
GBM antibodies is bound to underestimate  their frequency in nephritics  for 
several reasons:  First,  sera obtained from patients  with  their kidneys would 
have low levels of antibody at best, since the kidneys would remove much of it 
from the circulation as was observed in sheep with experimental nephritis; sec- 
ond, sera from the nephrectomized end stage chronic glomerulonephritics  might 
well have much lower levels of antibody than would have been present earlier 
in the disease because of loss of glomerular antigenic stimulation and any im- 
munosuppressive effects of uremia and debilitation; and third, our test system 
is not the most sensitive nor is it certain that the antigens employed contained 
all the GBM determinants.  Thus our observed incidence  of two patients with 
circulating anti-GBM antibodies of the 23 nephrectomized glomerulonephfitics 
is doubtless too low. Significantly,  the two nephrectomized patients who did 
have circulating anti-GBM antibodies had rapidly progressing  disease and did 
not have a prolonged period of terminal renal failure prior to nephrectomy. It is 
possible  that  more  extensive  immunofluorescent  studies  might  positively 
identify additional  anti-GBM  containing  sera.  The incidence  of four of nine 
glomerulonephritic kidney eluates containing anti-GBM antibodies is probably 
more realistic,  although the series is too small to allow definitive conclusions. 
Perhaps the best idea of the frequency of anti-GBM antibodies can be obtained 
from immunofluorescent staining of renal biopsies taken during early or active 
disease for host IGG or ~1c. Such observations in our experience agree approxi- 
mately with the kidney eluate data. If host IGG and ~,c are present in a dis- 
tinct,  sharp,  linear  pattern  along the GBM, this is presumptive evidence of 
anti-GBM antibodies. Using this criterion,  it appears that anti-GBM antibodies 
are present in: (a) all cases of Goodpasture's disease now studied, (b) somewhat 
less than half of the cases of subacute chronic glomerulonephritis  of adults, (c) a 
smaller proportion of the membranous glomerulonephritides  of children,  and 
(d) few if any, of the acute poststreptococcal glomerulonephritides  and lupus 
nephritides.  That  this pathogenetic mechanism may also  affect human renal 
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the glomerular capillary walls in  several allotransplants in which glomerular 
lesions and persistent  proteinuria developed soon after transplantation.  6 Such 
glomerular localization of IGG and/~1c has  not been a feature of allograft in- 
jection alone  6 (28). 
The data presented above suggest that, if anti-GBM antibody can be demon- 
strated either in the circulation or fixed to the kidneys of patients with glomeru- 
lonephritis,  such  patients  are  relatively poor  prospects  for  immediate renal 
transplantation. Although these data are preliminary, it would seem  that pa- 
tients producing  anti-GBM  antibodies may well develop early glomerulone- 
phritis in a transplanted kidney. Such recurrent glomerulonephritis in the trans- 
plant, if severe,  may be mistaken for homograft rejection as happened in two 
of the six cases reported here. Whether immunosuppressive therapy, especially 
during the anephric period prior  to transplantation, will  suffice  to  terminate 
anti-GBM antibody production is not certain, but the successful allografting 
of one of the Goodpasture's disease patients in this series  would suggest that 
this may be the case. 
SUMMARY 
These observations established the presence of anti-GBM antibodies in  the 
sera and/or kidneys of six humans with glomerulonephritis. Further, it  seems 
clear  that these  antibodies do combine with  the  host's glomeruli in  vivo  and 
with GBM antigen of several species in vitro. 
Transfer of acute glomerulonephritis to normal recipient monkeys was possi- 
ble  with serum or renal eluate IGG from the three patients with anti-GBM 
antibodies in whom sufficient material  was  available.  Based on this  transfer 
of nephritis and on the presence of these antibodies at the site of injury in the 
nephritic  kidneys of both  the patients  and  the  recipient monkeys, it  seems 
likely that they are at least a  contributing, if not primary,  cause of  the glo- 
merular injury. 
The frequency of anti-GBM antibodies in human nephritis is not certain, but 
on the basis of preliminary observations it would appear that they are present 
in all cases of Goodpasture's nephritis and somewhat less than half of the cases 
of subacute and chronic glomerulonephritis of adults. 
The nature and source of immunogen stimulating the production of anti- 
GBM antibodies is not known, but the presence of potentially nephritogenic 
GBM antigens in normal urine raises the question of possible autoimmunization. 
From a practical point of view, it appears  that patients forming anti-GBM 
antibodies may not be good candidates for renal transplantation since they are 
likely to produce in the transplants the nephritic changes already suffered by 
their own kidneys. 
Note Added in Proof.--Since this manuscript was submitted, kidneys from 15 pa- 
tients with glomuleronephritis have been eluted.  Anti-GMB  antibody was demon- 
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strated in the eluates from 3 of the 15. Of the positive eluates, one was from a patient 
with  Goodpasture's disease and  two were from patients with chronic glomerulone- 
phritis. 
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EXPLANATION OF PLATES 
PLATE 72 
FIG. 1.  Section of the biopsy obtained from G.L. 29 days after renal transplantation. 
This section  was incubated with rabbit anti-human IGG. Note the linear deposition 
of IGG along the glomerular capillary walls. The inserts emphasize the linear deposi- 
tion of IGG at higher magnification.  ×  450. 
FIG. 2.  A glomerulus  from the kidney of patient R.G. with Goodpasture's disease 
incubated with rabbit anti-human IGG. Note the linear deposition  of IGG along the 
glomerular capillary walls.  ×  350. THE  JOURNAL OF  EXPERIMENTAL  MEDICINE VOL. 126  PLATE  72 
(Lerner et al.: Anti-glomerular antibody in human nephritis) PLATE 73 
FIG. 3.  A low power (a) and a high power (b) photograph of a glomerulus from pa- 
tient V.U. with subacute glomerulonephritis. The section was incubated  with rabbit 
anti-human IGG. The linear distribution along GBM should be noted.  X 325;600. THE  JOURNAL  OF EXPERIMENTAL  MEDICINE  VOL.  126  PLATE  73 
(Lerner et al.: Anti-glomerular antibody in human nephritis) PLATE 74 
FIG. 4.  A  glomerulus from  a  normal kidney which  was  first  incubated with  the 
eluate from the kidney shown in Fig. 2 and then stained with rabbit anti-human IGG. 
The insert is a portion of another glomerulus from the same section. Note the linear 
deposition of IGG along the glomerular capillary wall, as well as Bowman's capsule. 
X  450. 
FIG. 5.  A glomerulus from a  monkey 24 hr after  the injection of globulin eluted 
from the kidney of patient V.U. with subacute glomerulonephritis. Note the prolifera- 
tion of fixed glomerular ceils.  X  350. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  126  PLATE  74 
(Lerner et al.: Anti-glomerular antibody in human nephritis) PLATE 75 
FIG. 6.  A  glomerulus from  the  monkey kidney biopsied 24  hr  a~ter  injection of 
globulin eluted from a kidney of patient R,G. with Goodpasture's disease. This section 
had been incubated with rabbit anti-human IGG and demonstrates the localization 
of the injected globulin in a linear fashion along GBM.  X  350. 
F~G. 7.  A lower power view of the same section shown in Fig. 6 showing the specific 
localization of the injected globulin to the glomeruli. X  250. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 126  PLATE  75 
(Lerner et al.: Anti-glomerular antibody in human nephritis) PLATE 76 
FIG. 8.  A low power view of three glomeruli showing proliferation of fixed glomeru- 
lar cells from a monkey 6 days after the injection of globulin eluted from the kidney 
shown in Fig. 3.  X 200. 
FIG. 9.  A high power view of a single glomerulus from the same section shown in 
Fig.  8  illustrating more  clearly  the  marked proliferation of  fixed  glomerular cells. 
X  350. THE JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  126  PLATE  76 
(Lerner et al.: Anti-glomerular antibody in human nephritis) 